Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA rejects bid to market antidepressant to treat foggy thinking
FDA rejects bid to market antidepressant to treat foggy thinking
FDA rejects bid to market antidepressant to treat foggy thinking
Submitted by
admin
on March 29, 2016 - 11:17am
Source:
Stat
News Tags:
Takeda
Lundbeck
FDA
antidepressants
Brintellix
Headline:
FDA rejects bid to market antidepressant to treat foggy thinking
Do Not Allow Advertisers to Use My Personal information
